Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Cardiologists believe Ozempic and Wegovy could help prevent heart disease. Dr. Marc Gibber, medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East, stopped by ...